The public health impact of Paxlovid COVID-19 treatment in the United States.

Yuan BaiZhanwei DuLin Wang Eric Ho Yin Lau Isaac Chun-Hai FungPetter HolmeBenjamin John CowlingAlison P GalvaniRobert M KrugLauren Ancel Meyers

Published in: medRxiv : the preprint server for health sciences (2023)

Mass treatment of symptomatic COVID-19 cases with antivirals that rapidly arrest SARS-CoV-2 replication would substantially reduce the spread and burden of the pandemic.

Keyphrases

sars cov
coronavirus disease
public health
respiratory syndrome coronavirus
risk factors